Advisor Net Financial, Inc Vertex Pharmaceuticals Inc Transaction History

Advisor Net Financial, Inc

$1.13 Billion
Q4 2024

A detailed history of Advisor Net Financial, Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Net Financial, Inc holds 1,356 shares of VRTX stock, worth $651,327. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,356

Previous 1,340 1.19%

Holding current value

$651,327

Previous $623,000 12.36%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$396.64 - $516.74 $6,346 - $8,267	16 Added 1.19%	1,356 $546,000
Q3 2024 Oct 15, 2024	BUY	$460.0 - $505.78 $33,120 - $36,416	72 Added 5.68%	1,340 $623,000
Q2 2024 Jul 16, 2024	BUY	$392.81 - $485.53 $32,210 - $39,813	82 Added 6.91%	1,268 $594,000
Q1 2024 Apr 12, 2024	BUY	$407.69 - $446.08 $21,607 - $23,642	53 Added 4.68%	1,186 $495,000
Q4 2023 Jan 19, 2024	BUY	$343.0 - $410.68 $3,087 - $3,696	9 Added 0.8%	1,133 $461,000
Q3 2023 Oct 12, 2023	SELL	$338.18 - $362.46 $11,498 - $12,323	-34 Reduced 2.94%	1,124 $390,000
Q2 2023 Jul 14, 2023	SELL	$314.42 - $351.91 $9,747 - $10,909	-31 Reduced 2.61%	1,158 $407,000
Q1 2023 Apr 28, 2023	SELL	$283.23 - $323.1 $3,398 - $3,877	-12 Reduced 1.0%	1,189 $374,000
Q4 2022 Jan 13, 2023	BUY	$285.76 - $321.48 $13,716 - $15,431	48 Added 4.16%	1,201 $0
Q3 2022 Oct 04, 2022	BUY	$273.83 - $305.53 $15,882 - $17,720	58 Added 5.3%	1,153 $334,000
Q2 2022 Jul 07, 2022	BUY	$234.96 - $292.55 $5,169 - $6,436	22 Added 2.05%	1,095 $309,000
Q1 2022 Apr 14, 2022	BUY	$221.42 - $260.97 $1,549 - $1,826	7 Added 0.66%	1,073 $280,000
Q4 2021 Jan 19, 2022	BUY	$177.01 - $223.45 $20,002 - $25,249	113 Added 11.86%	1,066 $234,000
Q3 2021 Oct 15, 2021	SELL	$181.39 - $202.99 $89,788 - $100,480	-495 Reduced 34.19%	953 $173,000
Q2 2021 Jul 06, 2021	BUY	$187.49 - $221.1 $14,624 - $17,245	78 Added 5.69%	1,448 $292,000
Q1 2021 Apr 14, 2021	BUY	$207.02 - $241.31 $1,656 - $1,930	8 Added 0.59%	1,370 $294,000
Q4 2020 Feb 04, 2021	SELL	$207.01 - $276.09 $828 - $1,104	-4 Reduced 0.29%	1,362 $322,000
Q3 2020 Nov 06, 2020	SELL	$255.65 - $303.1 $47,806 - $56,679	-187 Reduced 12.04%	1,366 $372,000
Q2 2020 Aug 26, 2020	SELL	$225.48 - $295.8 $17,361 - $22,776	-77 Reduced 4.72%	1,553 $451,000
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $13,584 - $16,851	68 Added 4.35%	1,630 $388,000
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $24,673 - $33,138	-148 Reduced 8.65%	1,562 $342,000
Q3 2019 Oct 23, 2019	BUY	$166.23 - $187.09 $54,024 - $60,804	325 Added 23.47%	1,710 $290,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $4,420 - $5,256	27 Added 1.99%	1,385 $255,000
Q4 2018 Feb 08, 2019	SELL	$151.91 - $192.21 $4,861 - $6,150	-32 Reduced 2.3%	1,358 $225,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $27,507 - $31,609	-164 Reduced 10.55%	1,390 $268,000
Q2 2018 Jul 27, 2018	BUY	$145.72 - $169.96 $29,872 - $34,841	205 Added 15.2%	1,554 $264,000
Q4 2017 Feb 27, 2018	BUY	$137.28 - $155.55 $185,190 - $209,836	1,349	1,349 $202,000

Others Institutions Holding VRTX

# of Institutions

1,752

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $123B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account

Advisor Net Financial, Inc Vertex Pharmaceuticals Inc Transaction History